Compass Therapeutics

IPO

Developing next generation antibodies into transformative cancer therapies

Public · Cambridge, United States · Founded 2014 · $332.0M raised

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$332.0M
Last Round
$120.0M Venture RoundAug 2025
Rounds
3
Type
Public

About

Compass Therapeutics is a clinical-stage oncology biopharmaceutical company developing proprietary antibody-based therapeutics that target the tumor microenvironment. Their platforms enable rapid identification of therapeutic leads bridging the innate and adaptive immune system, with candidates designed to optimize critical components of anti-tumor immune responses. The company trades on Nasdaq under the ticker CMPX.

Summary

Compass Therapeutics is a Biotech company based in Cambridge, United States, founded in 2014. It has raised $332.0M in total across 3 rounds, most recently a $120.0M Venture Round round in Aug 2025. Investors include OrbiMed, F-Prime Capital and Alumni Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundVenture RoundAug 2025
$120.0M

Sign up to see all 4 rounds

Series A through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Compass Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/compass-therapeutics"><img src="https://indexed.vc/api/badge/company/compass-therapeutics" alt="Compass Therapeutics on Indexed.vc" width="260" height="76" /></a>